Summary
Updated Aug 30, 2026
Lee Su-Leng Tan is Chief Executive Officer, Director, 10% Owner of BioNexus Gene Lab Corp (BGLC). 1 SEC Form 4 filing on record, dated 14 August 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Lee Su-Leng Tan has reported, most recent first.
Most Active Insiders Right Now
Lee Su-Leng Tan has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Vyacheslav Kim - $119.18M of KSPI open-market activity in the last 90 days
- Olivier Pomel - $118.60M of DDOG open-market activity in the last 90 days
- Ronda E. Stryker - $117.78M of SYK open-market activity in the last 90 days
- Gang Ye - $117.60M of SE open-market activity in the last 90 days
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 90 days
- Albert L. Lord - $116.13M of APCX open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Lee Su-Leng Tan?
Lee Su-Leng Tan is a corporate insider, tracked as Chief Executive Officer, Director, 10% Owner of BioNexus Gene Lab Corp (BGLC). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Lee Su-Leng Tan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Lee Su-Leng Tan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Lee Su-Leng Tan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
